Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

NovoCure Limited (NVCR)

110.74   1.76 (1.61%) 09-20 19:03
Open: 107.26 Pre. Close: 108.98
High: 110.98 Low: 106.42
Volume: 6,726,130 Market Cap: 11,195M
NovoCure Ltd. develops treatment for tumors. The firm is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Its TTFields delivery system is used for the treatment of glioblastoma (GBM) and to advance programs testing of TTFields in multiple solid tumor indications through its clinical pipeline. In addition to its clinical and commercial progress in GBM, it is planning or conducting clinical trials evaluating the use of TTFields in brain metastases, non-small-cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and mesothelioma. TTFields are delivered through a portable, medical device. The complete delivery system, which is designed to allow patients to go about their daily activities while receiving continuous cancer treatment, includes a portable electric field generator, transducer arrays, rechargeable batteries and accessories.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 106.634 - 106.949 106.949 - 107.302
Low: 96.313 - 96.673 96.673 - 97.077
Close: 103.784 - 104.363 104.363 - 105.011

Technical analysis

as of: 2020-09-18 4:33:59 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 124.47     One year: 145.39
Support: Support1: 86.57    Support2: 74.21
Resistance: Resistance1: 106.57    Resistance2: 124.47
Pivot: 85.61
Moving Average: MA(5): 92.85     MA(20): 83.82
MA(100): 69.73     MA(250): 75.06
MACD: MACD(12,26): 5.47     Signal(9): 3.81
Stochastic oscillator: %K(14,3): 93.64     %D(3): 89.84
RSI: RSI(14): 85.99
52-week: High: 106.57  Low: 53.40  Change(%): 31.5
Average Vol(K): 3-Month: 98313  10-Days: 121914

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NVCR has closed above the upper band by 20.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 128.9% wider than normal. The large width of the bands suggest high volatility as compared to NVCR's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Sat, 19 Sep 2020
Novocure (NASDAQ:NVCR) Cut to Equal Weight at Wells Fargo & Company - MarketBeat

Fri, 18 Sep 2020
NovoCure Limited (NVCR) Breaks into New 52-Week High on September 18 Session - Equities.com

Fri, 18 Sep 2020
Looking Closely at the Growth Curve for NovoCure Limited (NVCR) - newsheater.com

Thu, 17 Sep 2020
NovoCure Limited (NVCR) last month performance of 40.01% certainly makes it a sizzling prospect - News Daemon

Wed, 16 Sep 2020
Novocure (NVCR) COO Wilhelmus Cm Groenhuysen Sold $7.7 million of Shares - Yahoo Finance

Wed, 16 Sep 2020
Where Will Novocure Ltd (NVCR) Stock Go Next After It Has Gained 26.90% in a Week? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Health Care Equipment & Services
Shares Out. (M) 101
Shares Float (M) 83
% Held by Insiders 16.00
% Held by Institutions 70.48
Shares Short (K) 3,290
Shares Short P. Month (K) 3,080

Stock Financials

EPS 0.110
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.650
Profit Margin 2.88
Operating Margin 1.86
Return on Assets (ttm)
Return on Equity (ttm) 5.5
Qtrly Rev. Growth 33.7
Gross Profit (p.s.) 2.602
Sales Per Share 4.046
EBITDA (p.s.) 0.147
Qtrly Earnings Growth
Operating Cash Flow (M) 37
Levered Free Cash Flow (M) 16

Stock Valuations

PE Ratio 949.64
PEG Ratio
Price to Book value 39.42
Price to Sales 25.82
Price to Cash Flow 288.76

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.